register

Medical and Science

Did COVID-19 come from a lab in Wuhan?

Health Industry Hub | April 22, 2020 |

Medical News: Speculation that the virus that causes COVID-19 originated in a Wuhan lab has been given some weight, as the Trump Administration has announced an investigation into the matter. Is there any scientific evidence to support this?

Professor Edward Holmes is an evolutionary virologist and a member of the Charles Perkins Centre and the Marie Bashir Institute for Infectious Diseases and Biosecurity at the University of Sydney.

“Coronaviruses like SARS-CoV-2 are commonly found in wildlife species and frequently jump to new hosts. This is also the most likely explanation for the origin of SARS-CoV-2.
 
The closest known relative of SARS-CoV-2 is a bat virus named RaTG13, which was kept at the Wuhan Institute of Virology. There is some unfounded speculation that this virus was the origin of SARS-CoV-2.

Register FREE and join 22,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

However (i) RaTG13 was sampled from a different province of China (Yunnan) to where COVID-19 first appeared; and (ii) the level of genome sequence divergence between SARS-CoV-2 and RaTG13 is equivalent to an average of 50 years (and at least 20 years) of evolutionary change. Hence, SARS-CoV-2 was not derived from RaTG13.
 
In addition, we know that viruses related to SARS-CoV-2 are also found in pangolins. This suggests that other wildlife species are likely to carry relatives of SARS-CoV-2.
 
In summary, the abundance, diversity and evolution of coronaviruses in wildlife strongly suggests that SARS-CoV-2 is of natural origin.”

Nikolai Petrovsky is a Professor in the College of Medicine and Public Health at Flinders University. He is also Research Director, Vaxine Pty Ltd. He has a different opinion.

“An extremely important but still unanswered question is what was the source of COVID-19 virus. While COVID-19 has close similarities to SARS and other bat viruses no natural virus matching to COVID-19 has been found in nature despite an intensive search to find its origins. This raises the very legitimate question of whether the COVID-19 virus might be the result of human intervention.  

Certainly, our and other analyses of the genomic sequence of the virus do not reveal any artificial gene inserts that would be the hallmark of a gene jockey, genetic engineers who manipulate or even create viruses by splicing in artificial inserts into their genome. These are generally easily recognisable and hence clear signatures of human intervention in the creation of a virus. The fact that these artificial inserts are not present has been interpreted by some to mean this virus is not the result of human manipulation.

However, this logic is incorrect as there are other ways in which humans can manipulate viruses and that is caused by natural selection. What do I mean? All viruses and bacteria mutate and adapt to their environment over time, with selection of the fittest individuals for survival in that particular environment.

Take a bat coronavirus that is not infectious to humans, and force its selection by culturing it with cells that express human ACE2 receptor, such cells having been created many years ago to culture SARS coronaviruses and you can force the bat virus to adapt to infect human cells via mutations in its spike protein, which would have the effect of increasing the strength of its binding to human ACE2, and inevitably reducing the strength of its binding to bat ACE2.

Viruses in prolonged culture will also develop other random mutations that do not affect its function. The result of these experiments is a virus that is highly virulent in humans but is sufficiently different that it no longer resembles the original bat virus. Because the mutations are acquired randomly by selection there is no signature of a human gene jockey, but this is clearly a virus still created by human intervention.

My group in collaboration with other Australian researchers have been using a modelling approach to study the possible evolutionary origins of COVID-19 by modelling interactions between its spike protein and a broad variety of ACE2 receptors from many animals and humans.

This work which we will publish on a prepress server next week shows that the strength of binding of COVID-19 to human ACE2 far exceeds the predicted strength of its binding to the ACE2 of any of the other species. This points to the virus having been selected for its high binding to human ACE2.  In the absence of evidence of historic human infections with this virus, which could result in such selection, this either is a remarkable coincidence or a sign of human intervention.

This, plus the fact that no corresponding virus has been found to exist in nature, leads to the possibility that COVID-19 is a human-created virus. It is therefore entirely plausible that the virus was created in the biosecurity facility in Wuhan by selection on cells expressing human ACE2, a laboratory that was known to be cultivating exotic bat coronaviruses at the time. Is so the cultured virus could have escaped the facility either through accidental infection of a staff member who then visited the fish market several blocks away and there infected others, or by inappropriate disposal of waste from the facility that either infected humans outside the facility directly or via a susceptible vector such as a stray cat that then frequented the market and resulted in transmission there to humans.

Whilst the facts cannot be known at this time, the nature of this event and its proximity to a high-risk biosecurity facility at the epicentre of the outbreak demands a full and independent international enquiry to ascertain whether a virus of this kind of COVID-19 was being cultured in the facility and might have been accidentally released.”

You may also like Systemic review reveals COVID-19 droplets travel up to 8 metres


News & Trends - Pharmaceuticals

Will the new PBS campaign pressure the government to act?

Will the new PBS campaign pressure the government to act?

Health Industry Hub | September 18, 2024 |

Pharma News: The medicines industry is ramping up its campaign to slash delays in patient access to new and innovative […]

More


News & Trends - MedTech & Diagnostics

Private hospitals struggle despite surge in admissions: Financial crisis worsens as inflation outpaces benefits

Private hospitals struggle despite surge in admissions: Financial crisis worsens as inflation outpaces benefits

Health Industry Hub | September 18, 2024 |

MedTech & Diagnostics News: Private hospital admissions are on the rise, but this uptick is not enough to counter the […]

More


Digital & Innovation

Health sector and government under scrutiny: Record data breaches expose millions

Health sector and government under scrutiny: Record data breaches expose millions

Health Industry Hub | September 18, 2024 |

Digital & Innovation: The national privacy regulator has raised alarm over escalating threats, reporting a record surge in data breach notifications. […]

More


Medical and Science

Diabetes research funding plummets by 35%: Consultation launched to reverse decline

Diabetes research funding plummets by 35%: Consultation launched to reverse decline

Health Industry Hub | September 18, 2024 |

Medical & Science: Australia’s diabetes crisis is deepening, with calls for urgent action growing louder. The Standing Committee on Health, […]

More


This content is copyright protected. Please subscribe to gain access.